Health Care & Life Sciences » Pharmaceuticals | Supreme Pharmaceuticals Inc.

Supreme Pharmaceuticals Inc. | Income Statement

Fiscal year is July-June. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
6.30
3.90
14.60
203.30
583.60
22,971.10
Gross Income
6.30
3.90
14.60
203.30
583.60
14,116.40
SG&A Expense
129.70
1,705.80
5,466.20
4,091.60
18,032.30
5,286
EBIT
288.70
1,714.60
5,480.80
4,295.00
18,615.80
19,402.50
Unusual Expense
303.70
261.70
274.30
1.70
459.50
14,556.70
Non Operating Income/Expense
9.20
1.10
4.40
8.60
-
1,390.70
Interest Expense
10.40
13.30
41.80
81.50
175.80
363.60
Pretax Income
611.80
1,990.60
5,792.40
4,386.80
18,332.10
6,600.10
Income Tax
-
-
-
-
3,064.90
747
Consolidated Net Income
611.80
1,990.60
5,792.40
4,386.80
15,267.20
7,347.10
Net Income
611.80
1,990.60
5,792.40
4,386.80
15,267.20
7,347.10
Net Income After Extraordinaries
611.80
1,990.60
5,792.40
4,386.80
15,267.20
7,347.10
Net Income Available to Common
611.80
1,990.60
5,792.40
4,386.80
15,267.20
7,347.10
EPS (Basic)
0.05
0.10
0.08
0.05
0.09
0.03
Basic Shares Outstanding
9,634.90
23,816.60
73,529.90
97,413.80
164,793.10
223,827.20
EPS (Diluted)
0.06
0.08
0.08
0.05
0.09
0.03
Diluted Shares Outstanding
9,634.90
23,816.60
73,529.90
97,413.80
164,793.10
223,827.20
EBITDA
282.40
1,710.70
5,466.20
4,091.60
18,032.30
18,231.10
Other Operating Expense
152.60
4.90
-
-
-
-
Non-Operating Interest Income
0.20
-
-
-
-
-

About Supreme Pharmaceuticals

View Profile
Address
178R Ossington Avenue
Toronto Ontario M6J 2Z7
Canada
Employees -
Website http://www.supreme.ca
Updated 07/08/2019
The Supreme Cannabis Co., Inc. engages in the development and distribution of medical cannabis and related products. The company was founded on June 12, 1979 and is headquartered in Toronto, Canada. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.